79 related articles for article (PubMed ID: 1731454)
1. Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina.
Chaudhary H; Crozier I; Hamer A; Foy S; Shirlaw T; Ikram H
Am J Cardiol; 1992 Jan; 69(3):173-5. PubMed ID: 1731454
[TBL] [Abstract][Full Text] [Related]
2. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
Gold HK; Johns JA; Leinbach RC; Yasuda T; Grossbard E; Zusman R; Collen D
Circulation; 1987 Jun; 75(6):1192-9. PubMed ID: 3105913
[TBL] [Abstract][Full Text] [Related]
3. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
Williams DO; Topol EJ; Califf RM; Roberts R; Mancini GB; Joelson JM; Ellis SG; Kleiman NS
Circulation; 1990 Aug; 82(2):376-83. PubMed ID: 2115407
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo].
Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina.
Romeo F; Rosano GM; Martuscelli E; Comito M; Cardona N; Colistra C; Milano B; Bianco C; Rosano V
J Am Coll Cardiol; 1995 May; 25(6):1295-9. PubMed ID: 7722124
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina.
Nicklas JM; Topol EJ; Kander N; O'Neill WW; Walton JA; Ellis SG; Gorman L; Pitt B
J Am Coll Cardiol; 1989 Feb; 13(2):434-41. PubMed ID: 2492325
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.
Ardissino D; Barberis P; De Servi S; Mussini A; Rolla A; Visani L; Specchia G
Am J Cardiol; 1990 Oct; 66(12):910-4. PubMed ID: 2121016
[TBL] [Abstract][Full Text] [Related]
9. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
[TBL] [Abstract][Full Text] [Related]
10. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
Goldhaber SZ; Agnelli G; Levine MN
Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
Freeman MR; Langer A; Wilson RF; Morgan CD; Armstrong PW
Circulation; 1992 Jan; 85(1):150-7. PubMed ID: 1728444
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.
Kalbfleisch J; Thadani U; LittleJohn JK; Brown G; Magorien R; Kutcher M; Taylor G; Maddox WT; Campbell WB; Perry J
Am J Cardiol; 1992 May; 69(14):1120-7. PubMed ID: 1575179
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
15. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
Neri Serneri GG; Gensini GF; Poggesi L; Trotta F; Modesti PA; Boddi M; Ieri A; Margheri M; Casolo GC; Bini M
Lancet; 1990 Mar; 335(8690):615-8. PubMed ID: 1969013
[TBL] [Abstract][Full Text] [Related]
16. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
Deguchi I; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
[TBL] [Abstract][Full Text] [Related]
17. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty.
van den Brand M; van Zijl A; Geuskens R; de Feyter PJ; Serruys PW; Simoons ML
Eur Heart J; 1991 Nov; 12(11):1208-14. PubMed ID: 1782951
[TBL] [Abstract][Full Text] [Related]
19. [A randomized clinical trial on comparison of weight-adjusted dose with low dose recombinant tissue-type plasminogen activator on Chinese patients with acute myocardial infarction].
Jiang SL; Zhang Y; Ji XP; Zhang L; Song ZF
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1102-5. PubMed ID: 16563280
[TBL] [Abstract][Full Text] [Related]
20. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.
Mori E; Yoneda Y; Tabuchi M; Yoshida T; Ohkawa S; Ohsumi Y; Kitano K; Tsutsumi A; Yamadori A
Neurology; 1992 May; 42(5):976-82. PubMed ID: 1579252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
